1.
Lynch AM, Harper T, Holman NS, Tessier Y, Guerard M, Andersson P, Elloway J, Moggs J, Crosby M, Whiteley L, den Besten C, Jensen L, Schaefer K, Achanzar W, Amuzie C, Floettmann E, Parry JD. Is the genetic toxicology assessment of oligonucleotide therapies warranted?. sema [Internet]. 2023 May 12 [cited 2024 Jul. 25];27(1):175. Available from: https://ojs.diffundit.com/index.php/sema/article/view/1501